Alzheimers New Drug Approved by FDA Storyboard
بحث

Alzheimers New Drug Approved by FDA

قم بإنشاء Storyboard
انسخ هذه القصة المصورة
Alzheimers New Drug Approved by FDA
إنشاء الخاصة بك! ينسخ

القصة المصورة الوصف

PME 815

نص القصة المصورة

  • الانزلاق: 1
  • News Stand
  • “Alzheimer’s Cure Approved by FDA – Only One Pill Needed!”
  • الانزلاق: 2
  • “Wow, I should share this!” -- Texts a friend
  • الانزلاق: 3
  • “Are you sure it’s real? We should use facts checking tools, try to find the original source and verify and check other sources just to make sure.”
  • Skepticism ensues....
  • الانزلاق: 4
  • Searches for information on the FDA’s website, discovering that the new Alzheimer’s treatment, Lecanemab, is not a cure and has limitations.
  • FDA
  • الانزلاق: 5
  • Let's consult the Mayo Clinic . They found that Lecanemab slows symptoms in early cases but has severe risks, including brain swelling.
  • الانزلاق: 6
  • “Imagine if social media flagged questionable health news and provided a ‘Read More’ option to check reliable sources.”
  • Maybe platforms could highlight credible sources when using information from them .
  • الانزلاق: 7
  • Another source shows the drug costs $26,500 annually. That’s not affordable for everyone, jeepers!
  • الانزلاق: 8
  • So basically, Lecanemab helps some early-stage patients but isn’t a cure, comes with risks, and is expensive.
  • الانزلاق: 9
  • “To be a responsible digital citizen, always verify health claims and question headlines.”
  • الانزلاق: 10
  • Sources:Alzheimer's Association. “Donanemab for Treatment of Early Alzheimer’s Disease — News Pending FDA Review.” Alzheimer’s Disease and Dementia, 2023, www.alz.org/alzheimers-dementia/treatments/donanemab. Canadian Teachers’ Federation. (2021, February 22). Break the fake [Video]. YouTube. https://www.youtube.com/watch?v=qHeNabULAE0 Salam, Erum. “FDA Approves Breakthrough Alzheimer’s Drug Lecanemab.” The Guardian, 6 Jan. 2023, www.theguardian.com/us-news/2023/jan/06/fda-approves-breakthrough-alzheimers-drug-lecanemab.Stiepan, DeeDee. “Alzheimer’s Drug Lecanemab Granted Full Approval by FDA, Mayo Clinic Expert Weighs In.” Mayo Clinic News Network, 6 July 2023, newsnetwork.mayoclinic.org/discussion/alzheimers-drug-lecanemab-granted-full-approval-by-fda-mayo-clinic-expert-weighs-in/.
تم إنشاء أكثر من 40 مليون لوحة قصصية
لا توجد تنزيلات ولا بطاقة ائتمان ولا حاجة إلى تسجيل الدخول للمحاولة!
إنشاء لوحة العمل الأولى الخاصة بي
Storyboard That العائلة